- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 31.03. | IMAC Holdings, Inc. - 15-12G, Securities registration termination | - | SEC Filings | ||
| 19.03. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 19.03. | Aditxt beruft Jeff Busch an die Spitze der Tochtergesellschaft Ignite Proteomics | 1 | Investing.com Deutsch | ||
| 19.03. | Aditxt names Jeff Busch CEO of Ignite Proteomics subsidiary | 2 | Investing.com | ||
| 13.03. | Aditxt acquires Ignite Proteomics in $36M preferred stock deal; shares down | 1 | Seeking Alpha | ||
| 13.03. | Aditxt acquires precision oncology firm Ignite Proteomics | 2 | Investing.com | ||
| 13.03. | Aditxt übernimmt Präzisionsonkologie-Unternehmen Ignite Proteomics | 2 | Investing.com Deutsch | ||
| 27.02. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| IMAC HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 18.02. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 30.01. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.01. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 17.12.25 | IMAC Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 16.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 01.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.11.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | IMAC Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 31.10.25 | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.09.25 | IMAC Holdings, Inc.: Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers | 205 | GlobeNewswire (Europe) | The First Precision Oncology Trial to Use a Functional Proteomics and Phosphoproteomics Assay for Treatment Decision Making in a Pan-Tumor Study Golden, CO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ignite... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 5,430 | -2,34 % | Plus Therapeutics Inc.: Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline | HOUSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| LIFEWARD | 6,530 | +1,40 % | Lifeward Ltd.: Lifeward Successfully Closes on Strategic Partnership with Oramed | HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
| EKSO BIONICS | 9,235 | 0,00 % | EKSO BIONICS HOLDINGS, INC. - 10-K/A, Annual Report | ||
| IMUNON | 2,660 | +5,56 % | Imunon, Inc.: IMUNON Reports 2025 Financial Results and Provides Business Update Highlighting Significant Progress with Pivotal Phase 3 Study | IMNN-001 is the first frontline immunotherapy to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with advanced ovarian cancer Final Phase 2... ► Artikel lesen | |
| ROCKWELL MEDICAL | 0,780 | -1,89 % | H.C. Wainwright cuts Rockwell Medical stock price target to $2 on sales miss | ||
| VIRIDIAN THERAPEUTICS | 12,800 | +1,59 % | Aktien New York Ausblick: US-Börsen vor erholtem Start | NEW YORK (dpa-AFX) - In einem weiterhin von Nervosität geprägten Umfeld könnten die US-Börsen am Montag im frühen Handel wieder einen Erholungsversuch starten. Nach den deutlichen Kursverlusten, die... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 2,850 | -1,38 % | SINTX Technologies, Inc.: SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution | Clinical milestone, new President appointment, and platform expansion position SINTX for commercial rollout and revenue growth in 2026 SALT LAKE CITY, Utah, March 23, 2026 (GLOBE NEWSWIRE) -- SINTX... ► Artikel lesen | |
| AETHLON MEDICAL | 2,200 | 0,00 % | Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review | SAN DIEGO, March 24, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a clinical-stage biotechnology company developing the investigational Aethlon Hemopurifier®... ► Artikel lesen | |
| NEURONETICS | 1,215 | +2,97 % | Neuronetics: Optum/United Healthcare/United Behavioral Health Expands NeuroStar TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners | ||
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | StageZero Life Sciences Ltd.: StageZero Announces Partial Revocation of Failure to File Cease Trade Order and Proposed Financing | ||
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 15-12G, Securities registration termination | ||
| HVIVO | 0,117 | +54,97 % | hVIVO PLC - hVIVO launches unified brand identity | ||
| FRESENIUS | 44,850 | +0,81 % | Fresenius: S&P Global erhöht Ausblick - jetzt zugreifen? | Unter der Leitung von Konzernchef Michael Sen hat sich Fresenius einem Umbau unterzogen. Randbereiche wurden verkauft, die Effizienz gesteigert und schlussendlich auch der Schuldenabbau forciert. Das... ► Artikel lesen |
Das Unternehmen IMAC HOLDINGS INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMAC HOLDINGS INC finden Sie auf Wallstreet Online.